 The agency also carries out investigations and takes enforcement action against illegal activities related to unregistered, counterfeit and adulterated health products.HSA has an established and active pharmacovigilance programme that draws on its network of healthcare professionals and overseas regulators.This allows HSA to initiate targeted and prompt action in response to reported adverse drug reports and expedite the isolation of such problems and minimise harm to public health and safety.